Alzheimer's disease: genes, proteins and therapy, Physiol. Rev, vol.81, p.11274343, 2001. ,
Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, p.1566067, 1992. ,
Alzheimers disease, Lancet, vol.368, pp.387-403, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01098836
,
, Alzheimer's disease: molecular understanding predictsamyloid-based therapeutics, Annu. Rev. Pharmacol. Toxicol, vol.43, p.12415125, 2003.
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI, Proc. Natl. Acad. Sci. U. S. A, vol.101, issue.13, p.15070770, 2004. ,
Alzheimer's disease: a disorder of cortical cholinergic innervation, Science, vol.219, p.6338589, 1983. ,
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease, Neurochem. Int, vol.45, issue.5, p.15234100, 2004. ,
Current approaches in the treatment of Alzheimer's disease, Biomed. Pharmacother, vol.62, issue.4, p.18407457, 2008. ,
Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, vol.2, issue.8000, p.1403, 1976. ,
Efiicacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis, C.M.A.J, vol.169, issue.6, pp.557-564, 2003. ,
Natural oligomers of the Alzheimer amyloid-beta induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependant signalling pathway, J. Neurosci, vol.27, pp.2866-2875, 2007. ,
, , p.17360908, 2007.
A beta-oligomer induced abberation in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease, J. Neurosci, vol.27, pp.796-807, 2007. ,
, , p.17251419, 2007.
A specific amyloid-beta protein assembly in the brain impairs memory, Nature, vol.440, p.16541076, 2006. ,
Recent advances in the neurochemistry of Alzheimer's disease, J. Clin. Psychiatry, vol.48, p.2883177, 1987. ,
Neurochemical changes in the aging human brain: implications for behavioural impairment and neurodegenerative disease, Geriatrics, vol.53, p.9745628, 1998. ,
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies, Prog. Neurobiol, vol.68, issue.3, p.12450488, 2002. ,
Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease, Expert Opin. Drug Metab. Toxicol, vol.10, p.24785550, 2014. ,
Donepezil for dementia due to Alzheimer's disease, Cochrane Database Syst. Rev, p.16437430, 2006. ,
Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment, Mol. Med. Rep, vol.6, issue.6, p.23023803, 2012. ,
Donepezil, a centrally acting acetyl ChE inhibitor, alleviates learning deficits in hypocholinergic models in rats, Methods Find. Exp. Clin. Pharmacol, vol.22, p.10849891, 2000. ,
Efficacy of memantine hydrochloride once-daily in Alzheimer's disease, Expert Opin. Pharmacother, vol.15, issue.13, p.25085661, 2014. ,
Memantine for dementia, Cochrane Database Syst. Rev, vol.003154, p.16625572, 2006. ,
Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6 month study, J. Alzheimers Dis, vol.11, p.17656827, 2007. ,
Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease, J. Pharmacol. Exp. Ther, vol.311, p.15192085, 2004. ,
Lacomblez L; French research network on Frontotemporal dementia. Memantine in behavioural variant fronto temporal dementia, J. Alzheimers Dis, vol.23, issue.4, p.21157021, 2011. ,
Low doses of memantine disrupt memory in adult rats, J. Neurosci, vol.26, p.16611808, 2006. ,
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systemic review, Pharmacol. Res, vol.61, p.20193764, 2010. ,
Long-term cholinesterase inhibitor therapy for Alzheimer's disease: practical considerations for the primary care physician, Prim. Care Companion J. Clin. Psychiatry, vol.5, issue.6, p.15213795, 2003. ,
The effects of donepezil in Alzheimer's disease results from a multinational trial, Dement. Geriatr. Cogn. Disord, vol.10, issue.3, p.10325453, 1999. ,
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis, Int. J. Geriatr. Psychiatry, vol.23, issue.5, p.18058838, 2008. ,
Effectiveness of cholinesterase inhibitors and mematine for treating dementia: evidence review for a clinical practice guideline, Ann. Intern. Med, vol.148, issue.5, p.18316756, 2008. ,
We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective, Neurodegener. Dis, vol.13, issue.2-3, p.24401335, 2014. ,
Animal model of Alzheimer's disease and drug development, Drug Discov. Today Technol, vol.10, issue.3, p.24050129, 2013. ,
The grey mouse lemur: a non-human primate model for ageing studies, Ageing Res. Rev, vol.11, issue.1, p.21802530, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00650159
Age-related cerebral atrophy in non-human primates predicts cognitive impairments, Neurobiol. Aging, vol.33, issue.6, p.20970891, 2012. ,
, Donepezil or memantine limit sleep-deprivation-induced memory deficit in young and aged non-human primate, PLOS ONE, 2017.
The use of non-human primate in research, The Weatherall report, 2006. ,
Effects of dietary resveratrol on the sleep-wake cycle in the non-human primate grey mouse lemur (Microcebus murinus), Chronobiol. Int, vol.29, issue.3, p.22390239, 2012. ,
Once-daily memantine: pharmacokinetic and clinical considerations, J. Am. Geriatr. Soc, vol.58, issue.9, p.20863351, 2010. ,
Pharmacokinetic study of memantine in healthy and renally impaired subjects, Clin. Pharmacol. Ther, vol.79, issue.1, p.16413248, 2006. ,
Free radical scavenging effect of donepezil as the possible contribution to its memory enhancing activity in mice, Drug Res. (Stuttg), vol.64, issue.5, pp.236-239, 2014. ,
Memory defect induced by ß-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms, Brain Res, vol.1441, p.22305339, 2012. ,
Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice, Am. J. Pathol, vol.176, pp.870-880, 2010. ,
Wisniewski T. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-diseasemodel transgenic mice shown as by micromagnetic resonance imaging, J. Neurosci. Res, pp.224-57, 2008. ,
Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine, Eur. J. Pharmacol, vol.703, issue.1-3, p.23276665, 2013. ,
Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats, Neuropharmacology, vol.61, issue.5-6, p.21704049, 2011. ,
The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat, Behav. Brain Res, vol.36, issue.1-2, p.2302323, 1990. ,
Coping with sleep deprivation: shifts in regional brain activity and learning strategy, Sleep, vol.33, issue.11, p.21102988, 2010. ,
The scopolamine model as a pharmacodynamic marker in early drug development, Psychopharmacology (Berl), vol.220, issue.1, pp.97-107, 2012. ,
The effects of novel ChE inhibitors and selective muscarinic receptor agonists in test of reference and working memory, Behav. Brain Res, vol.57, p.8117420, 1993. ,
Reversal of scopolamine induced spatial memory deficits in rats by TAK-147, Acta Pharmacol. Sin, vol.23, issue.4, p.11931694, 2002. ,
Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease, Psychopharmacology (Berl), vol.230, issue.2, pp.279-289, 2013. ,
Cholinergic augmentation modulates visual task performance in sleep-deprived young adults, J. Neurosci, vol.28, issue.44, p.18971479, 2008. ,
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation, Sleep, vol.32, issue.8, p.19725251, 2009. ,
An inverted U-shaped curve for hepatylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors, Eur. J. Pharmacol, vol.302, issue.1-3, p.8790986, 1996. ,
Cholinergic receptor interactions and their effects on long-term memory processing, Brain Res, vol.215, issue.1-2, p.7260586, 1981. ,
Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations, J. Neurosci, vol.10, p.1967639, 1990. ,
Neurotransmitters and second messengers in aging and Alzheimer's disease, Ann. NY. Acad. Sci, vol.695, p.7902054, 1993. ,
Excitatory amino acids and Alzheimer's disease, Neurobiol. Aging, vol.10, p.2554168, 1989. ,
Cognitive evaluation of disease modifying efficacy of galantamine and memantine in APP23 model, Eur. Neuropsychopharmacol, vol.16, issue.1, p.16095884, 2006. ,
Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus, Neuropharmacology, vol.85, p.24878242, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02309703
The NMDA antagonist memantine impairs classical eyeblink conditioning in humans, Neurosci. Lett, vol.224, p.9132691, 1997. ,
Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans, Neurobiol. Learn. Mem, vol.8, pp.20-25, 2001. ,
Effects of NMDA receptor antagonist memantine on mismatch negativity, Brain Res. Bull, vol.72, p.17452287, 2007. ,
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial, JAMA, vol.291, p.14734594, 2004. ,
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease, Arch. Neurol, vol.63, p.16401736, 2006. ,
Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?, Genes Brain Behav, vol.5, issue.2, p.16507003, 2006. ,
Deficits of psychomotor and mnesic functions across aging in mouse lemur primates, Front Behav Neurosci, vol.9, p.25620921, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01230922
Effects of memantine and galantamine on cognitive performance in aged rhesus macaques, Neurobiol Aging, vol.34, p.23158762, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01218078